Key TakeawaysGLP-1 receptor agonists improve outcomes in patients with coronary plaque and post-STEMI, reducing adverse cardiovascular events and hospitalizations.Patients using GLP-1s show higher event-free survival and improved lipid profiles, despite elevated triglycerides.GLP-1 therapy demonstrates potential as a novel treatment avenue for cardiovascular conditions, with significant implications for future management strategies.Studies found that glucagon-like peptide-1 (GLP-1) […]
